Pricing Log in Create free account
Friday 6 November 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.

Revenue
−7.01%
EPS
−101.0%
Free cash flow
+561.9%
Total debt
−90.1%

Quarter to September 2026, against a year earlier

86.56 2.79 −3.12%
Market cap
$14.8B
P/E
97.3×
Fwd P/E
47.7×
Dividend yield
—
F-score
5/9
Altman Z
2.22
Beneish M
−2.07
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Solventum Corporation (SOLV) EBITDA

Alert me on EBITDA

Solventum Corporation's EBITDA for fiscal 2025 was $2.7B, up 67.8% from $1.6B in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.6B. Solventum Corporation ranks 5th of 47 Medical Instruments & Supplies companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $2.7B 67.82%
FY2024 $1.6B (29.38%)
FY2023 $2.3B (0.79%)
FY2022 $2.3B —

Quarterly newest first

Period EBITDA Change
Jun 2026 $314.0M 46.05%
Mar 2026 $215.0M (11.16%)
Dec 2025 $242.0M (86.64%)
Sep 2025 $1.8B 438.99%
10 more quarters

EBITDA against peers

Company EBITDA
SOLV Solventum Corporation $2.6B
BAX Baxter International Inc. compare $1.5B
WST West Pharmaceutical Services, Inc. compare $964.5M
COO The Cooper Companies, Inc. compare $928.2M
AVTR Avantor, Inc. compare $913.6M
ALGN Align Technology, Inc. compare $802.0M
BLCO Bausch + Lomb Corporation compare $801.0M
ATR AptarGroup, Inc. compare $783.0M
RGEN Repligen Corporation compare $155.0M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on SOLV